We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

46 hedge funds and large institutions have $5.44M invested in REVIVA PHARMA HLDGS INC in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,704% more call options, than puts

Call options by funds: $2.25M | Put options by funds: $23K

0.7% more ownership

Funds ownership: 0.79% → 1.49% (+0.7%)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

4% less funds holding

Funds holding: 48 → 46 (-2)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

22% less capital invested

Capital invested by funds: $6.95M → $5.44M (-$1.5M)

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
9
Closed
12
Calls
$2.25M
Puts
$23K
Net Calls
+$2.23M
Net Calls Change
+$4.11M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.1M
2
DP
Diadema Partners
New Jersey
+$1.62M
3
HCM
Heights Capital Management
California
+$1.42M
4
6CM
683 Capital Management
New York
+$779K
5
PAP
Persistent Asset Partners
Hong Kong
+$374K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$487K
2
Marshall Wace
Marshall Wace
United Kingdom
-$206K
3
PAG
Private Advisor Group
New Jersey
-$191K
4
UBS Group
UBS Group
Switzerland
-$174K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$8K +$3.12K +200 +23%
DWM
27
Drive Wealth Management
Utah
$7.62K – – –
Raymond James Financial
28
Raymond James Financial
Florida
$5.72K -$109 -7 -0.9%
Charles Schwab
29
Charles Schwab
California
$5.72K – – –
NWM
30
NRI Wealth Management
California
$4.72K – – –
TWC
31
TD Waterhouse Canada
Ontario, Canada
$4.6K +$9.35K +600 +2,400%
SA
32
Sanctuary Advisors
Indiana
$4.19K – – –
IAS
33
Insigneo Advisory Services
Florida
$3.81K – – –
Northwestern Mutual Wealth Management
34
Northwestern Mutual Wealth Management
Wisconsin
$3.54K – – –
SS
35
SBI Securities
Japan
$1.91K +$3.91K +251 New
Morgan Stanley
36
Morgan Stanley
New York
$1.57K – – –
IA
37
IFP Advisors
Florida
$1.52K -$701 -45 -18%
Wells Fargo
38
Wells Fargo
California
$1.14K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$543 -$5.31K -341 -83%
AWM
41
Activest Wealth Management
Florida
$381 – – –
Jones Financial Companies
42
Jones Financial Companies
Missouri
$283 – – –
WAM
43
Wolverine Asset Management
Illinois
$168 +$343 +22 New
Bank of America
44
Bank of America
North Carolina
$166 +$62 +4 +22%
TCM
45
Tradewinds Capital Management
Washington
$96 – – –
UBS Group
46
UBS Group
Switzerland
$76 -$174K -11,167 -100%
TCM
47
Tang Capital Management
California
– -$487K -25,516 Closed
Marshall Wace
48
Marshall Wace
United Kingdom
– -$206K -10,825 Closed
PAG
49
Private Advisor Group
New Jersey
– -$191K -10,000 Closed
NA
50
NewEdge Advisors
Louisiana
– -$58.1K -3,045 Closed
1
2
3

RVPH Hedge Fund Activity: Q2 2025 in Review

46 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q2 2025, worth a combined $5.44M — down 22% from $6.95M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RVPH and 11 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 8 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.1M. The largest seller was Tang Capital Management, exiting entirely with an estimated $487K sold.

  • 46 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q2 2025, down from 48 in Q1 2025.
  • Funds reported $5.44M of REVIVA PHARMA HLDGS INC stock for Q2 2025, down 22% quarter-over-quarter.
  • 11 funds opened new REVIVA PHARMA HLDGS INC positions in Q2 2025 and 12 closed out, a net change of -1 holder.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q2 2025 was Armistice Capital, an estimated $2.1M added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q2 2025 was Tang Capital Management, an estimated $487K sold.

Based on aggregated 13F filings for Q2 2025.